Long intergenic non-protein coding RNA 2230 (LINC02230)

Long intergenic non-protein coding RNA 2230 (LINC02230) is a member of the long intergenic non-coding RNA (lincRNA) subclass of long non-coding RNAs. LincRNAs are autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap coding regions of the genome and lack protein-coding function[3][7]. They are implicated in the regulation of gene expression through diverse mechanisms such as chromatin remodeling, modulation of transcription, participation in RNA processing, and possible enhancer-like activities[3][5][7]. Although dysregulation of many lincRNAs has been associated with disease processes including cancers and neurological disorders, there is no direct evidence or peer-reviewed functional characterization published for LINC02230 as a specific therapeutic target, biomarker, or drug-interacting molecule as of now[1]. The understanding of LINC02230's precise biological and pathological function remains limited and largely unelucidated.

Other names

LINC02230